Advisory & Consulting Services

Lupus Therapeutics’ consulting service, part of our full suite of services to streamline the research process, enables our biopharmaceutical company partners to harness the drug development expertise of LuCIN key opinion leaders, who are luminaries in the field.


Our consulting service connects this network with our industry partners for synergistic collaboration on lupus clinical research development and planning. Through this effort, we seek to improve the quality and outcomes of lupus clinical trials, improve recruitment rates, and reduce barriers throughout the trial process.


Early engagement between industry and LuCIN leads to more effective clinical development plans and pragmatic study designs. This results in faster development and launch of potential new therapies for people with lupus.


As the go-to organization for lupus research, we offer a seasoned team of experts with significant lupus experience to provide customized consulting services at any phase of the drug development or clinical research process.

Consulting may include input on:

  • Pipeline prioritization and clinical development plans
  • Protocol review and trial design
  • Acceptable endpoints for lupus clinical studies
  • Regulatory planning and advisory board meetings
  • Patient-reported outcome development plans and tools
  • Protocol-operations feasibility